Basic Information
| LncRNA/CircRNA Name | LINC01140 |
| Synonyms | NA |
| Region | GRCh38_1:87129765-87169198 |
| Ensemble | ENSG00000267272 |
| Refseq | NR_026985 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | other |
| Sample | GEPIA |
| Expression Pattern | down-regulated |
| Function Description | LINC01140 expression was significantly decreased in the tumor samples compared with normal samples in patients with BC.LINC01140 expression was significantly decreased in the T4 stage compared with T1, T2 or T3 stage .interaction between microRNA (miR)-200b and miR-200c with LINC011440. higher expression of LINC01140 was beneficial for patients with BC. LINC01140 may be a potential biomarker for the prognosis of patients with BC. |
| Pubmed ID | 31966045 |
| Year | 2020 |
| Title | Downregulation of LINC01140 Is Associated With Adverse Features of Breast Cancer |
External Links
| Links for LINC01140 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |